4.3 Review

Antibiotic stewardship: overcoming implementation barriers

期刊

CURRENT OPINION IN INFECTIOUS DISEASES
卷 24, 期 4, 页码 357-362

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QCO.0b013e3283483262

关键词

antibiotic de-escalation; antibiotic stewardship; care bundles

资金

  1. Astellas
  2. Janssen-Cilag
  3. Merck
  4. Sharp Dohme
  5. Novartis
  6. Pfizer

向作者/读者索取更多资源

Purpose of review Antimicrobial stewardship is now recognized as a formal strategy for curbing the upward trend in antibiotic resistance. Literature on antimicrobial stewardship has focused on areas of strategic importance and operational delivery. A number of barriers have been recognized in the implementation of successful programs. These include lack of physician participation, lack of diagnostic facility, absence of formal mechanism of data collection, variation between countries, and lack of cooperative strategies. In this review, we suggest strategies to overcome these barriers. Recent findings In the last few years, it has been recognized that an executive program is necessary for successful implementation of strategies to control the growing antibiotic resistance. Efforts have been made at higher levels of government through organizations such as the European Centre for Disease Prevention and Control. The need for community healthcare involvement has also been recognized. At a local level, strategies to promote cooperation between various committees (e. g. infection control and antimicrobial management teams) have been proposed and adopting antibiotic care bundles as part of patient safety and healthcare is being explored. Summary We suggest that executive level planning, local cooperation, sustained education, emphasis on de-escalation, and use of care bundles could stem the tide of growing resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据